HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy.

AbstractPURPOSE:
A Phase I trial of cranial neutron capture therapy (NCT) was conducted at Harvard-MIT. The trial was designed to determine maximum tolerated NCT radiation dose to normal brain.
METHODS AND MATERIALS:
Twenty-two patients with brain tumors were treated by infusion of boronophenylalanine-fructose (BPA-f) followed by exposure to epithermal neutrons. The study began with a prescribed biologically weighted dose of 8.8 RBE (relative biologic effectiveness) Gy, escalated in compounding 10% increments, and ended at 14.2 RBE Gy. BPA-f was infused at a dose 250-350 mg/kg body weight. Treatments were planned using MacNCTPlan and MCNP 4B. Irradiations were delivered as one, two, or three fields in one or two fractions.
RESULTS:
Peak biologically weighted normal tissue dose ranged from 8.7 to 16.4 RBE Gy. The average dose to brain ranged from 2.7 to 7.4 RBE Gy. Average tumor dose was estimated to range from 14.5 to 43.9 RBE Gy, with a mean of 25.7 RBE Gy.
CONCLUSIONS:
We have demonstrated that BPA-f-mediated NCT can be precisely planned and delivered in a carefully controlled manner. Subsequent clinical trials of boron neutron capture therapy at Harvard and MIT will be initiated with a new high-intensity, high-quality epithermal neutron beam.
AuthorsMatthew R Palmer, J Timothy Goorley, W S Kiger, Paul M Busse, Kent J Riley, Otto K Harling, Robert G Zamenhof
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 53 Issue 5 Pg. 1361-79 (Aug 01 2002) ISSN: 0360-3016 [Print] United States
PMID12128139 (Publication Type: Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Boron
Topics
  • Adult
  • Aged
  • Boron (blood)
  • Brain (radiation effects)
  • Brain Neoplasms (radiotherapy)
  • Female
  • Glioblastoma (radiotherapy)
  • Humans
  • Male
  • Melanoma (radiotherapy)
  • Middle Aged
  • Neutron Capture Therapy (methods)
  • Neutrons
  • Phantoms, Imaging
  • Radiometry (methods)
  • Radiotherapy Planning, Computer-Assisted (methods)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: